Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA.
Placental malaria is a major health problem for both pregnant women and their fetuses in malaria endemic regions. It is triggered by the accumulation of Plasmodium falciparum-infected erythrocytes (IE) in the intervillous spaces of the placenta and is associated with foetal growth restriction and ma...
Guardado en:
Autores principales: | Sisse B Ditlev, Raluca Florea, Morten A Nielsen, Thor G Theander, Stefan Magez, Philippe Boeuf, Ali Salanti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9796993b115b40e59cdd32de388a16ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification and characterization of B-cell epitopes in the DBL4ε domain of VAR2CSA.
por: Sisse B Ditlev, et al.
Publicado: (2012) -
Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
por: Vera V Pinto, et al.
Publicado: (2011) -
Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA.
por: Pernille Andersen, et al.
Publicado: (2008) -
The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner
por: Mette Ø. Agerbæk, et al.
Publicado: (2018) -
An upstream open reading frame controls translation of var2csa, a gene implicated in placental malaria.
por: Borko Amulic, et al.
Publicado: (2009)